| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Specific rotation | +8.5 to +10.5 deg(C=1, water) |
| Solubility | Slightly soluble  in water |
Active Pharmaceutical Ingredients
Brimonidine Tartrate
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine Tartrate; 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine Tartrate; 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-Dihydroxysuccinate
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C11H10BrN5·C4H6O6 = 442.23 |
| Storage Temperature | Refrigerated (0-10°C) |
| CAS RN | 70359-46-5 |
| Unit | Price |
| 1 g | 7500 |
| 5 g | 22000 |
| 10 g | 39500 |
| Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|
